glp-1 and general anesthesia Outpatient Sedation Basics for Patients on Medications Here's what your anesthesia team
Description
JAMA Netw Open 2024;7:e2413172
Ethical factors clarify treatment goals and ensure we meet legal standards

Thymosin Beta-4 (TB4) Strength: 15 mg Advanced option for patients seeking broader provider-guided recovery support
Similar trials are assessing GLP-1RAs in overweight patients with IBD (110), in UC (NCT06937086), and exploring dual GLP-1/GIP agonists like Zepbound as adjunctive therapies (NCT06774079) (112)
Option Structure: Elevated IV after headlines favors credit structures on mean-revert days

For people tired of injections, this could provide a meaningful alternative to cycling between injectable options